PGEN
Price
$1.50
Change
+$0.17 (+12.78%)
Updated
Jun 6 closing price
Capitalization
392.59M
64 days until earnings call
TVRD
Price
$28.50
Change
+$4.00 (+16.33%)
Updated
Jun 6 closing price
Capitalization
229.06M
Interact to see
Advertisement

PGEN vs TVRD

Header iconPGEN vs TVRD Comparison
Open Charts PGEN vs TVRDBanner chart's image
Precigen
Price$1.50
Change+$0.17 (+12.78%)
Volume$3.69M
Capitalization392.59M
Tvardi Therapeutics
Price$28.50
Change+$4.00 (+16.33%)
Volume$63.58K
Capitalization229.06M
PGEN vs TVRD Comparison Chart
Loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PGEN vs. TVRD commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a Hold and TVRD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (PGEN: $1.37 vs. TVRD: $30.86)
Brand notoriety: PGEN and TVRD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 128% vs. TVRD: 171%
Market capitalization -- PGEN: $392.59M vs. TVRD: $229.06M
PGEN [@Biotechnology] is valued at $392.59M. TVRD’s [@Biotechnology] market capitalization is $229.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileTVRD’s FA Score has 1 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • TVRD’s FA Score: 1 green, 4 red.
According to our system of comparison, TVRD is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 5 TA indicator(s) are bullish while TVRD’s TA Score has 3 bullish TA indicator(s).

  • PGEN’s TA Score: 5 bullish, 1 bearish.
  • TVRD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than TVRD.

Price Growth

PGEN (@Biotechnology) experienced а +3.79% price change this week, while TVRD (@Biotechnology) price change was -5.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

PGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($393M) has a higher market cap than TVRD($229M). TVRD YTD gains are higher at: 404.248 vs. PGEN (22.321).
PGENTVRDPGEN / TVRD
Capitalization393M229M172%
EBITDA-123.5MN/A-
Gain YTD22.321404.2486%
P/E RatioN/AN/A-
Revenue3.93MN/A-
Total Cash97.9MN/A-
Total Debt5.5MN/A-
FUNDAMENTALS RATINGS
PGEN vs TVRD: Fundamental Ratings
PGEN
TVRD
OUTLOOK RATING
1..100
1124
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5334
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVRD's Valuation (5) in the null industry is significantly better than the same rating for PGEN (72). This means that TVRD’s stock grew significantly faster than PGEN’s over the last 12 months.

TVRD's Profit vs Risk Rating (100) in the null industry is in the same range as PGEN (100). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

PGEN's SMR Rating (99) in the null industry is in the same range as TVRD (100). This means that PGEN’s stock grew similarly to TVRD’s over the last 12 months.

TVRD's Price Growth Rating (34) in the null industry is in the same range as PGEN (53). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

TVRD's P/E Growth Rating (100) in the null industry is in the same range as PGEN (100). This means that TVRD’s stock grew similarly to PGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PGENTVRD
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
84%
Momentum
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
80%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 18 days ago
80%
Declines
ODDS (%)
Bearish Trend 26 days ago
84%
Bearish Trend about 1 month ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
83%
Aroon
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with ARWR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-2.84%
ARWR - PGEN
46%
Loosely correlated
+1.24%
CRSP - PGEN
45%
Loosely correlated
-0.92%
TRDA - PGEN
45%
Loosely correlated
+0.91%
IDYA - PGEN
45%
Loosely correlated
+0.72%
ALEC - PGEN
44%
Loosely correlated
+12.70%
More

TVRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVRD has been loosely correlated with APM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TVRD jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVRD
1D Price
Change %
TVRD100%
-7.58%
APM - TVRD
40%
Loosely correlated
-2.49%
COEP - TVRD
36%
Loosely correlated
-1.41%
NRXP - TVRD
28%
Poorly correlated
+0.39%
VSTM - TVRD
22%
Poorly correlated
-10.68%
PGEN - TVRD
21%
Poorly correlated
-2.84%
More